期刊文献+

糖皮质激素对系统性红斑狼疮患者骨代谢水平的影响 被引量:1

Influence of glucocorticoid to bone metabolism of patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的 了解糖皮质激素对系统性红斑狼疮 (SLE)患者骨代谢水平的影响。方法 用放射免疫分析法对 32例未经糖皮质激素治疗和 38例经糖皮质激素治疗的SLE患者的血清骨钙素 (BGP)和尿脱氧吡啶啉(DPD)进行测定 ,血Ca2 + 、P及AKP进行测定 ,并与 30名健康人进行对照。结果 未经糖皮质激素治疗组血清Ca2 + 、BGP水平较正常对照组明显下降 (P <0 0 5 ) ;尿DPD水平较正常对照组明显升高 (P <0 0 5 ) ;使用激素治疗后的SLE患者血清BGP水平较未使用组明显下降 (P <0 0 5 ) ,尿DPD水平明显升高 (P <0 0 5 )。结论 SLE患者本身就存在骨形成障碍和骨吸收增加 。 Objective To understand the influence of glucocorticoid to bone metabolism of patients with systemic lupus erythematosus (SLE).Methods Seventy patients with SLE and 30 matched normal controls were studied,the serum Ca 2+ ,P,AKP osteocalcin level and urine deoxypyridinoline level were measured by RIA.Results The serum osteocalcin level of SLE patients without glucocorticoid therapy was significantly lower than that of the normal subjects ( P <0 05),the serum osteocalcin level of SLE patients with glucocorticoid therapy was significantly lower than that of those without glucocorticoid therapy ( P <0 05),but the urine deoxypyridinoline level of SLE patients with glucocorticoid therapy significantly increased ( P <0 05).Conclusion Abnormal bone formation and decreased bone turnover exist in SLE patients;when the SLE patients receive glucocorticoid therapy,their abnormal bone metabolism becomes even more serious.
出处 《中国药物与临床》 CAS 2002年第6期361-362,共2页 Chinese Remedies & Clinics
关键词 糖皮质激素 系统性红斑狼疮 骨代谢 治疗 Glcocorticoids Lupus erythematosus,systemic Bone metabolism
  • 相关文献

参考文献8

  • 1佑腾和人,平谭玲子,小山典子.慢性关节リウマチと骨粗松症.内科,1995,76:898. 被引量:1
  • 2腾本清一 清野佳纪.骨形成マ—カ—[J].内科,1995,76:848-848. 被引量:1
  • 3Khoslas AK,Kleerekoper M.Biochemical markers of bone turnover.In:Favus MJ,eds.Primer on the Metabolic Bone in Diseases and Disorders of Mineral Metabolism.4th ed.London:Williams Wilkins,1999.128. 被引量:1
  • 4Gerrits MI,Thijssen JHH,Rijn HJM.Determination of pyridinoline and deoxypyridinoline in urine,with special attention to retaining their stability.Clin Chem,1995,41:571-574. 被引量:1
  • 5Hanson DA.A specific immunoassay for monitoring human bone resorption:quantitation of type I collagen crosslinked N-telopeptides in urine.J Bone Miner Res,1992,7:1251. 被引量:1
  • 6Venelhart D,Gineyts E,Chapuy M.Urinary excretion of pyridinium crosslinks:a new marker of bone resorption in metabolic bone disease.Bone Miner,1990,8:87-96. 被引量:1
  • 7佐藤斡ニ.ステロィド骨粗松症[J].内科,1995,76:889-889. 被引量:1
  • 8Hahn TJ,Westbrook SL,Halstead LR.Cortisol modulation of osteoblast metabolic activity in cultured neonatal rat bone.Endocrinology,1984,114:1864. 被引量:1

同被引文献34

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部